Astrana Health (NASDAQ:ASTH) Sets New 1-Year Low After Analyst Downgrade

Astrana Health, Inc. (NASDAQ:ASTH) reached a new 52-week low during trading on Monday after Truist Financial lowered their price target on the stock from $59.00 to $50.00. Truist Financial currently has a buy rating on the stock. Astrana Health traded as low as $29.08 and last traded at $29.42, with a volume of 13470 shares traded. The stock had previously closed at $29.48.

Other analysts also recently issued reports about the company. Robert W. Baird lifted their price objective on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. KeyCorp assumed coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating for the company. TD Cowen assumed coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 target price on the stock. BTIG Research lifted their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, Macquarie upgraded Astrana Health to a “hold” rating in a research note on Monday, December 16th. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $63.67.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ASTH. GAMMA Investing LLC acquired a new position in Astrana Health in the third quarter valued at approximately $34,000. Nisa Investment Advisors LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $35,000. KBC Group NV acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $70,000. Quarry LP acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $77,000. Finally, Quest Partners LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $133,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Trading Down 0.2 %

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of 22.63, a P/E/G ratio of 1.80 and a beta of 1.20. The company has a 50 day moving average price of $39.55 and a two-hundred day moving average price of $47.00.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same period in the prior year, the company earned $0.47 EPS. On average, research analysts forecast that Astrana Health, Inc. will post 1.16 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.